chr5-90685771-G-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_032119.4(ADGRV1):c.6275-9G>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000939 in 1,596,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032119.4 splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ADGRV1 | NM_032119.4 | c.6275-9G>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000405460.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ADGRV1 | ENST00000405460.9 | c.6275-9G>T | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_032119.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151616Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000969 AC: 14AN: 1445058Hom.: 0 Cov.: 29 AF XY: 0.0000111 AC XY: 8AN XY: 719608
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151616Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74056
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 13, 2017 | The c.6275-9G>T variant in GPR98 has not been previously reported in individuals with hearing loss or Usher syndrome, but has been reported in 1/14982 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinsti tute.org). Although this variant has been seen in the general population, its f requency is not high enough to rule out a pathogenic role. This variant is locat ed in the 3' splice region. Computational tools do not suggest an impact to spli cing. However, this information is not predictive enough to rule out pathogenici ty. In summary, the clinical significance of the c.6275-9G>T variant is uncertai n. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 29, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at